[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health":3,"$flne4k4v2k6no":14},{"ok":4,"db":5,"lastOrangeBookRun":6,"lastDrugsFdaRun":9,"lastAlertsRun":12,"stale":13},true,"ok",{"status":5,"startedAt":7,"finishedAt":8,"lastOkAt":8},"2026-10-26T06:44:32.239Z","2026-10-26T06:44:53.640Z",{"status":5,"startedAt":10,"finishedAt":11,"lastOkAt":11},"2026-10-26T06:45:02.648Z","2026-10-26T06:45:13.189Z",null,false,{"tradeName":15,"ingredient":16,"applicant":17,"applicantSlug":18,"applNos":19,"loe":21,"latestLoe":21,"basis":22,"carveOutPossible":13,"openStrengths":23,"headlineStrengths":24,"headlineFallback":13,"products":25,"patents":35,"exclusivities":36,"paragraphIv":39,"catalysts":41},"VIDAZA","AZACITIDINE","BRISTOL-MYERS","bristol-myers",[20],"050794","2029-05-20","exclusivity",0,1,[26],{"key":27,"applNo":20,"productNo":28,"dosageForm":29,"route":30,"strength":31,"approvalDate":32,"rld":4,"teCode":33,"type":34,"loe":21,"basis":22,"carveOutPossible":13},"050794-001","001","POWDER","INTRAVENOUS, SUBCUTANEOUS","100MG\u002FVIAL","2004-05-19","AP","RX",[],[37],{"product":27,"code":38,"expireDate":21,"products":24},"ODE-399",{"asOf":12,"firstFiled":12,"entries":40},[],[]]